Plotted by close date where disclosed, otherwise announcement. Select any marker to jump to the deal entry.
Three patterns run through Doximity's acquisitions — what it looks for, how it pays, and how it folds in what it buys.
3 acquisitions — each with the deal value, financing structure, target revenue, and executive commentary where disclosed.
Doximity acquired THMED, LLC (subsequently renamed Curative Talent, LLC), a medical recruiting agency providing temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States.
In October 2020 Doximity sold a portion of the Curative Talent business for $4.7M total consideration, recognizing a non-recurring gain; the divested net assets were not material. Curative Talent, LLC remains a Doximity subsidiary.
Doximity acquired the assets of Amion, a leading web and mobile on-call scheduling and messaging application used by hospital scheduling staff and physicians. Founded in 1998 by Stuart Karon and based in the Boston area, Amion managed nearly 200,000 physician schedules across thousands of hospitals, including 18 of the top 20.
We're excited to partner with founder Stuart Karon and the Amion team to expand our physician cloud platform. Scheduling enhances our collaboration suite and will grow engagement across all our businesses.Jeff Tangney — CEO and co-founder, Doximity
For 24 years, Amion fostered a micro-company model to maximize operational efficiency. We're excited to add Doximity's growth gene to our DNA. Formalizing our decade-long partnership will bring great new tools to many more physicians.Stuart Karon — CEO and founder, Amion
Closed April 1, 2022. Contingent earn-out recorded as a liability; ~$6.0M settled in Q1 FY2024. Amion, LLC remains a Doximity subsidiary.
Doximity acquired all outstanding shares of Pathway Medical Inc., a Montreal-based, AI-based medical knowledge / clinical-reference platform. Over ~7 years Pathway assembled one of the largest AI-purpose-built structured datasets in medicine - spanning guidelines, drugs, and landmark trials across major specialties - and its model scored a record 96% on the USMLE benchmark. Physicians make up about half of Pathway's team.
They've painstakingly built one of the best datasets in medicine, and it's going to take our clinical reference capabilities to an entirely new level.Jeff Tangney — co-founder and CEO, Doximity
Closed July 29, 2025, announced August 7, 2025. Doximity began beta-testing the combined Pathway + Doximity GPT product with physicians.